The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

Illinois lawmakers are pushing an amendment to ban restrictions or interference with a federal discount drug program.

Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...

The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health ...

The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...

The American Hospital Association is once again raising concerns about how a major drugmaker handles the government’s 340B ...

By virtue of its exclusive contract to manage the 340B Drug Pricing Program since 2004, Apexus has become a government-sanctioned entity fraught with self-dealing interests in the 340B marketplace.

Community health centers that primarily serve low-income patients fear Gov. Bob Ferguson's proposed supplemental budget will hamper their ability to pa ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act. [i] The program, which is administered by the Health ...

The Acquisition Connects Pharmacy and Referral Intelligence to Help Covered Entities Simplify Workflows, Expand Access, and Grow 340B SavingsBOSTON & SHARON HILL, Pa.--(BUSINESS WIRE)--NuvemRx, a ...